1-9 of 9
Yusuke Nakauchi, MD
Close
Sort by
Journal Articles

Cytokine Rescue and Targeting of Inflammation-Sensitive RUNX1 Deficient Human CD34 + Hematopoietic Stem and Progenitor Cells

Amy Fan, Armon Azizi, BS, Kevin Nuno, BS, Yusuke Nakauchi, MD PhD, Feifei Zhao, MD, Andreas Reinisch, MD PhD, David Cruz Hernandez, MS, Ravindra Majeti, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-137173
Published: 2020
Journal Articles

Induction of Truncating ASXL1 Mutations in Human CD34+ HSPCs Mimics Human ASXL1-Mutated Clonal Hematopoiesis and Progression to Myeloid Malignancies

Thomas Koehnke, MD, Rajiv Sharma, PhD, Yusuke Nakauchi, MD PhD, Andreas Reinisch, MD PhD, Ravi Majeti, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 820.
https://doi.org/10.1182/blood-2019-130528
Published: 2019
Journal Articles

Enasidenib Drives Maturation of Human Erythroid Precursors Independently of IDH2

Ritika Dutta, BS, Tian Y Zhang, MD PhD, Thomas Koehnke, MD, Daniel Thomas, MD PhD, Eric Gars, MD, Melissa Stafford, Yusuke Nakauchi, MD PhD, Satinder Kaur, BS, Raymond Yin, Anupama Narla, MD, Ravindra Majeti, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 540.
https://doi.org/10.1182/blood-2019-124551
Published: 2019
Journal Articles

Azacitidine and Ascorbate Inhibit the Competitive Outgrowth of Human TET2 Mutant HSPCs in a Xenograft Model of Pre-Leukemia

Yusuke Nakauchi, MD PhD, Daniel Thomas, MD PhD, Rajiv Sharma, PhD, M. Ryan Corces, PhD, Andreas Reinisch, MD PhD, David Cruz, MS, Thomas Koehnke, MD PhD, Daiki Karigane, MDPhD, Amy Fan, BS, Ravindra Majeti, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 887.
https://doi.org/10.1182/blood-2018-99-113907
Published: 2018
Journal Articles

IDH1 Mutant AML Is Susceptible to Targeting De Novo Lipid Synthesis Independent of 2-Hydroxyglutarate and Has a Distinct Metabolic Profile from IDH2 Mutant AML

Daniel Thomas, MD PhD, Yusuke Nakauchi, MD PhD, Manhong Wu, PhD, Ming Zheng, PhD, Subarna Sinha, PhD, David Dill, PhD, Gary Peltz, MD PhD, Ravindra Majeti, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 440.
https://doi.org/10.1182/blood-2018-99-115040
Published: 2018
Journal Articles

An Engineered Cell-Traceable Model of Reticular Dysgenesis in Human Hematopoietic Stem Cells Linking Metabolism and Differentiation

Wenqing Wang, PhD, Avni Awani, PhD, Lauren Reich, Yusuke Nakauchi, MD PhD, Daniel Thomas, MD PhD, Daniel P. Dever, PhD, Matthew Porteus, MD PhD, Katja G. Weinacht, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2558.
https://doi.org/10.1182/blood-2018-99-117926
Published: 2018
Journal Articles

Characterization and Targeting TET2-Mutant HSPCs and AML

Yusuke Nakauchi, MD PhD, Daniel Thomas, MD PhD, Andreas Reinisch, MD PhD, Rajiv Sharma, PhD, David Cruz, BS, M. Ryan Corces, PhD, Ravi Majeti, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2509.
https://doi.org/10.1182/blood.V130.Suppl_1.2509.2509
Published: 2017
Journal Articles

Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death Via Large Pore Formation

Shuji Matsuoka, MDPhD, Yasuyuki Ishii, PhD, Atsuhito Nakao, MDPhD, Hiroshi Masutani, Satoshi Takahashi, MD PhD, Yusuke Nakauchi, MD, Okio Hino, MDPhD
Journal: Blood
Blood (2014) 124 (21): 5488.
https://doi.org/10.1182/blood.V124.21.5488.5488
Published: 2014
Journal Articles

Novel Therapeutic Approach To Graft-Versus-Host Disease With Allele-Specific Anti-HLA Monoclonal Antibody

Yusuke Nakauchi, MD, Satoshi Yamazaki, PhD, Stephanie Carlisle Napier, Jo-ichi Usui, MD, PhD, Yasunori Ota, MD, PhD, Satoshi Takahashi, MD, PhD, Nobukazu Watanabe, MD, PhD, Hiromitsu Nakauchi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4462.
https://doi.org/10.1182/blood.V122.21.4462.4462
Published: 2013